The Revolutionary CUBIC Organ/Body Atlas from UTokyo
In a landmark achievement for biomedical imaging, researchers at the University of Tokyo have unveiled the CUBIC Organ/Body Atlas, a groundbreaking three-dimensional map capturing every cell in major mouse organs and an entire neonatal mouse body at single-cell resolution. Published in the prestigious journal Cell on February 25, 2026, this atlas represents a pinnacle of systems biology, enabling unprecedented whole-organ and whole-body analysis that could transform pathology, drug development, and developmental studies. Led by Professor Hiroki R. Ueda from UTokyo's Graduate School of Medicine, the project builds on years of innovation in tissue clearing techniques, positioning Japanese higher education at the forefront of spatial omics research.
The atlas covers eleven adult mouse organs—including the brain, heart, lungs, liver, kidneys, spleen, pancreas, thymus, small intestine, bladder, and skin—along with a complete neonatal mouse body containing over 500 million cells. This resource allows scientists to compare cell distributions across samples quantitatively, revealing subtle variations that traditional two-dimensional pathology misses. For instance, it highlights organ-specific clustering of macrophages, suggesting specialized functions in immune surveillance.
Evolution of Tissue Clearing: From CUBIC Origins to Whole-Body Mapping
The foundation of this breakthrough lies in the CUBIC (Clear, Unobstructed Brain/Body Imaging Cocktails and Computational analysis) method, pioneered by Ueda's team since 2014. Initially developed for brain imaging, CUBIC uses advanced chemical cocktails to render tissues transparent while preserving their three-dimensional structure. Over the years, iterations like CUBIC-X and CUBIC-H have expanded its scope to whole organs and bodies, addressing challenges such as light scattering and tissue shrinkage.
At UTokyo, this technology has been refined through the JST ERATO Ueda Biodata Project (2020-2026), fostering interdisciplinary collaboration. The latest optimization ensures compatibility with immunostaining, allowing researchers to label specific cell types—like immune markers IBA1 for macrophages—before imaging. This evolution underscores how persistent innovation in Japanese universities drives global standards in microscopy.
Innovative Imaging: The exMOVIE System and Data Processing Pipeline
Central to the atlas is exMOVIE, a custom light-sheet fluorescence microscope designed by the UTokyo team. This system overcomes physical barriers in large-scale imaging by providing extended working distances and high axial resolution, essential for penetrating cleared tissues up to centimeters thick. Imaging a single adult mouse kidney, for example, generates terabytes of data, which are then processed using advanced algorithms for nuclei detection and 3D coordinate mapping.
The computational pipeline aligns these maps to a standardized reference space, enabling superposition of data from multiple animals or conditions. Publicly available on Zenodo (Zenodo dataset), the atlas empowers global researchers to download and analyze cell positions interactively.
Key Findings: Cell Distributions and Organ-Specific Patterns
Analysis of the atlas reveals striking insights into cellular architecture. In the neonatal whole-body map, approximately 610 million cells in males and 530 million in females are cataloged, providing a baseline for growth studies. Adult organs show heterogeneous cell densities; for example, the liver exhibits uniform distribution, while the spleen features dense macrophage clusters, hinting at localized immune roles.
Comparative applications demonstrate its power: developmental atlases track cell proliferation in kidney regions, while pathology models quantify doxorubicin-induced damage in hearts, correlating cell loss with toxicity hotspots. These findings, detailed in the Cell paper (Cell publication), validate the atlas's utility for precise, quantitative biology.
Transforming Disease Research: From 2D Pathology to 3D Cellomics
Traditional histopathology relies on thin slices, losing spatial context across organs. The CUBIC atlas introduces "3D pathology," where entire organs are scanned to map disease progression holistically. UTokyo researchers applied it to inflammation models, revealing systemic immune cell shifts post-lipopolysaccharide challenge, with macrophages migrating to affected sites.
In cancer research, it could delineate tumor microenvironments in 3D, improving immunotherapy targeting. Japanese institutions like Osaka University, collaborators on the project, are already integrating it with spatial transcriptomics for multi-omics profiling.
Photo by Rohit Choudhari on Unsplash
Insights into Development and Physiology
The neonatal whole-body atlas serves as a developmental reference, quantifying cell numbers in embryonic-like states. Comparisons with adult organs illuminate growth dynamics, such as nephron maturation in kidneys. Physiological studies benefit from baseline maps for tracking circadian rhythms or metabolic fluxes, aligning with Ueda's prior work on mouse proteomes.
This resource positions UTokyo as a hub for longitudinal cellomics, aiding Japan's push in regenerative medicine.
Whole-Body Immune Profiling: Macrophages and Beyond
Using 3D immunostaining, the atlas maps immune cells across organs. Macrophages cluster in spleen red pulp and liver sinusoids, suggesting tissue-specific adaptations. Whole-body profiling post-challenge shows dynamic redistribution, crucial for understanding sepsis or autoimmunity.
Future extensions could include T-cells or neurons, expanding to neuroscience collaborations at UTokyo.
UTokyo's Leadership in Japanese Biomedical Innovation
The University of Tokyo, Japan's premier research institution, spearheads this via the Graduate School of Medicine's Systems Pharmacology lab. Funded by JST ERATO, it exemplifies public-private synergy, with RIKEN and industry ties accelerating translation. Ueda's team, including postdocs like Shuichi Y. Yoshida and Etsuo A. Susaki, highlights talent cultivation in Japanese higher education.
In national rankings, UTokyo dominates life sciences, with this work boosting its QS subject score. It inspires similar initiatives at Kyoto University and Osaka University, strengthening Japan's global competitiveness in spatial biology.
Collaborations Driving Multi-Institutional Success
Partners include Osaka University Graduate School of Medicine, Juntendo University, Kurume University, and Iwate Medical University. This network, under ERATO, pools expertise in pathology, imaging, and computation. Satoshi Takagi from JFCR Cancer Institute adds oncology perspectives, exemplifying Japan's collaborative research ecosystem.
Such partnerships, common in MEXT-funded projects, enhance resource sharing amid shrinking budgets, fostering junior faculty growth.
Future Horizons: Human Translation and AI Integration
While mouse-focused, the pipeline targets human tissues, promising 3D digital pathology for precision medicine. UTokyo envisions AI-driven analysis for automated anomaly detection, aligning with Japan's Society 5.0 vision. Challenges like larger human organ scaling are next, with pilot studies underway.
Globally, it complements Allen Brain Atlas, but excels in whole-body scope. Japanese universities are poised to lead, attracting international talent.
Career Opportunities in Spatial Omics at Japanese Universities
This breakthrough opens doors for postdocs, faculty, and technicians in imaging, bioinformatics, and pathology. UTokyo and collaborators seek experts in light-sheet microscopy and AI segmentation. Japan's research ecosystem offers stable funding via JSPS grants, with high demand for interdisciplinary skills.
Programs like the Japan Society for the Promotion of Science fellowships support early-career researchers, making it an ideal landscape for advancing cellomics careers.